Immune response biomarkers as indicators of sarcoidosis presence, prognosis, and possible treatment: An Immunopathogenic perspective
Authors:
- 1 March 2020
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 19 (3) , 102462
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A sarcoidosis clinician’s perspective of MHC functional elements outside the antigen binding siteHuman Immunology, 2019
- Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic PerformanceFrontiers in Immunology, 2018
- Genetic, Immunologic, and Environmental Basis of SarcoidosisAnnals of the American Thoracic Society, 2017
- The Etiologic Role of Infectious Antigens in Sarcoidosis PathogenesisClinics in Chest Medicine, 2015
- Elevated serum BAFF levels in patients with sarcoidosis: association with disease activityRheumatology, 2013
- Active Chronic Sarcoidosis is Characterized by Increased Transitional Blood B Cells, Increased IL-10-Producing Regulatory B Cells and High BAFF LevelsPLOS ONE, 2012
- Disturbed Homeostasis and Multiple Signaling Defects in the Peripheral Blood B-Cell Compartment of Patients with Severe Chronic SarcoidosisClinical and Vaccine Immunology, 2011
- Higher Monocyte Expression of TLR2 and TLR4, and Enhanced Pro-inflammatory Synergy of TLR2 with NOD2 Stimulation in SarcoidosisJournal of Clinical Immunology, 2008
- HLA-DR Predicts the Prognosis in Scandinavian Patients with Pulmonary SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- "The Sarcoidosis Map": A Joint Survey of Clinical and Immunogenetic Findings in Two European CountriesAmerican Journal of Respiratory and Critical Care Medicine, 1995